Cedience
Information
Teams are spending hours searching through different databases to answer questions on regulatory expectations, past approvals and precedents.
Cedience is an AI-powered regulatory intelligence platform that answers your most complex questions almost instantly while helping you monitor the changes in the regulatory environment and the competitive landscape.
Here are just a few examples of the questions Cedience helps you answer.
Schedule your demo here and come meet our team at booth 1740
- What are FDA's guidelines on immunogenicity testing?
- Which products are approved for ulcerative colitis?
- Which endpoints have supported past approvals in triple negative breast cancer?
- Are there examples of FDA approval despite a failed primary endpoint?
- Which products are approved for Diffuse Large B-Cell Lymphoma (DLBCL) and have a warning for hepatotoxicity?
- Which products or companies have been granted Rare Pediatric Disease Designation (RPDD) and for which conditions?